In the current study, decomposition of diclofenac, diflunisal, ibuprofen, mefenamic acid and piroxicam was tested using nine identified strains of endophytic and epiphytic fungi (from Ascomycota) adapted to natural products resembling the pharmaceuticals. The strains were isolated from a medicinal plant, Plantago lanceolata leaves. Metabolites were tentatively identified by liquid chromatography -tandem mass spectrometry ).
Introduction
Non-steroid anti-inflammatory drugs (NSAIDs) are among the most frequently used drugs.
These medicine are used to treat common conditions associated with many diseases, e. g. fever and pain (Hudec et al., 2008) . The usage of high amounts results in appearance of these compounds and their metabolites in wastewater and also surface waters, as conventional wastewater treatment processes are unable to completely eliminate them (Domaradzka et al., 2015) . Despite not being present at high concentrations enough to cause acute toxicity (they are typically detected in the ng l -1 to µg l -1 range (Paíga et al., 2015) ), the risk of chronic toxicity can be significant (Domaradzka et al., 2015) . For some pharmaceuticals, including the NSAIDs ibuprofen and naproxen, the toxic concentration against Hydra attenuata was found to be close to that detected in wastewater effluents (Quinn et al., 2008) . Also, long-term exposure of fish to environmentally relevant concentrations of diclofenac is likely to cause impairment of the general health, and bioaccumulation (Schwaiger et al., 2004 ).
Significant research is ongoing to find microbial agents capable of decomposition of pharmaceuticals and other organic pollutants, like polyaromatic hydrocarbons (Harms et al., 2011) . The fungi, like all organisms, enzymatically modify xenobiotics in order to decrease or eliminate their toxicity, if possible. The ability to completely decompose -mineralize -xenobiotics is not common during biodegradation, though there are several interesting examples (Harms et al., 2011) .
Hydroxylation, or other minor modifications, however, are more common. This step can be very important: it decreases the lipophilicity of the compounds, thereby reducing their bioaccumulation potential (Esser, 1986) and increasing their water solubility, and hence, bioavailability to enzymes for later degradation steps. It also reduces their ability to bind to solids which can be very significant for non-polar compounds, as shown for the NSAID mefenamic acid by (Jones et al., 2005) . Also, hydroxylated compounds can have reduced toxicity compared to the original metabolite, as shown in the case of hydroxy-diclofenac metabolites in a yeast system (van Leeuwen et al., 2011) . In other cases, however, the hydroxy metabolites have been proven to be more toxic than the original compound. The metabolism of diclofenac (i.e. production of 5-hydroxy derivatives) correlated with toxicity in a hepatocyte model (Bort et al., 1999 ).
Several authors have described decomposition and/or transformation of NSAID drugs by fungi.
Most of these studies used one of the so-called white-rot fungi (Domaradzka et al., 2015) .
Decomposition of a wide range of NSAIDs and other drugs was achieved for example by Trametes versicolor Rodríguez-Rodríguez et al., 2010; Tran et al., 2010) . This species was also able to dechlorinate halogenated aromatics of high environmental persistence (Marco-Urrea et al., 2009a) . Several studies have shown the oxidative modification of these drugs. Production of 4',5-dihydroxy-diclofenac, 4',-hydroxy-diclofenac and 5-hydroxy-diclofenac from the NSAID diclofenac by Phanerochaete sordida was reported by (Hata et al., 2010) . The same fungus was shown to successfully metabolize mefenamic acid into several oxidized products, like 3-OH-mefenamic acid and 3-COOH-mefenamic acid (Hata et al., 2010) . The ibuprofen metabolism also consisted of oxidation (hydroxylation) steps in the case of Trametes versicolor, but the final product (1,2-dihydroxyibuprofen) was found to be new, and not previously described in biological systems (Marco-Urrea et al., 2009b) . Production of 4'-hydroxy-diclofenac by a non-white-rot fungal strain, Epicoccum nigrum was described by (Webster et al., 1998) .
The endophytic and epiphytic fungi of medicinal plants represent another group of fungi: they are not involved in wood decay as the white-rot fungi, but they also live in a special chemical environment. They are surrounded by plant molecules, among which phenolic and other aromatic substances are especially common. The adaptation to this chemically unique habitat makes these organisms a rich potential source of biocatalysts (Suryanarayanan et al., 2012 ).
In the current study, we aimed to assess the potential of a cosmopolitan plant rich in phenolic compounds, dried leaves of Plantago lanceolata L., as a source of fungi useful for the biotransformation of NSAIDs. The tested strains included endophytic fungal lines as well as ubiquitous fungi isolated from the plant material. These strains have been previously found to be able to produce a wide array of hydroxylated phenolics from the plant material, as well as decomposition of polyphenolic compounds (Gonda et al., 2013a) . We aimed to test these nine identified strains for their NSAID decomposition ability in model solutions. The NSAIDs included piroxicam and diflunisal for which no fungal transformation data were available. We also aimed to gain structural information on the major NSAID biotransformation products by LC-MS/MS. Stock solutions of NSAIDs were prepared in equimolar sodium carbonate solutions, filtered sterile and were stored at -24 ºC before use.
Materials and Methods

2
Fungal strains
Nine of the strains identified in one of our previous studies (Gonda et al., 2013a) were tested for NSAID decomposition abilities. The following strains were used: 1: Aspergillus niger; 2: Eurotium repens; 3: Leptosphaerulina chartatum; 4: Aspergillus nidulans; 5: Eurotium amstelodami; 6: Cladosporium pseudocladosporioides; 7: Penicillium chrysogenum; 8: Bipolaris tetramera; 9:
Epicoccum nigrum. The strains were isolated from a medicinal plant material rich in phenolic compounds. The isolation method resulted in a mixture of endophytes and epiphytic fungi. The rationale for testing these strains for NSAID biotransformation was the similarity of the NSAIDs and the phenolic compounds released by these strains from the plant material. The isolation method, the identification of the species and the gene accession numbers are described in (Gonda et al., 2013a) .
Activity screening for non-steroid anti-inflammatory drug decomposition by plant-associated fungi.
Sterile, 10 mL aliquots of Czapek-Dox liquid media (CzD, 3.0 g NaNO 3 ; 1.0 g K 2 HPO 4 ; 0.5 g Dish fully covered with mycelia was scraped off, and suspended into the liquid medium. Control was not inoculated. After mixing, the inoculated solution was separated into 250 µL aliquots and incubated in a sterile environment for 28 days. Evaporation was prevented by the saturation of the surrounding air with water vapor. After the end of incubation time, the aliquots were lyophilized, dissolved in 40 mM disodium phosphate containing 10% 1-PrOH, centrifuged at 13,000 rpm for 5 minutes and analyzed by capillary electrophoresis micellar electrokinetic chromatography (CE-MEKC) directly for residual NSAID amounts.
CE measurements were carried out on a PrinCE-C 700 capillary electrophoresis instrument with a 60 cm fused silica capillary with 50 µm i.d. Effective length was 52.8 cm. Capillary preconditioning and post-conditioning were previously described (Gonda et al., 2013b) . Sample injection was hydrodynamic (100 mbar × 0.10 min.), NSAIDs were quantified at 200 nm. Background electrolyte consisted of 40 mM disodium phosphate, 100 mM SDS, 3% MeOH, pH was set to 8.0. The method is adapted from (Maboundou et al., 1994 ) with a few modifications. Calibration curves contained mixtures of the five NSAIDs in 40 mM disodium phosphate containing 10% 1-PrOH. Concentrations of 25, 50, 75, 100, 125 and 150 µg mL -1 were used.
Identification of NSAID metabolites by LC-ESI-MS/MS
Fourteen fungus-NSAID pairs were selected for the study of NSAID metabolites. DIF was tested for decomposition by A. niger and A. nidulans; DIC by A. nidulans and B. tetramera; IBU and MEF by A. niger, A. nidulans, B. tetramera and E. nigrum; PIR by A. niger and A. nidulans. 5 .00 mL of CzD media were spiked with a single NSAID of interest (100 µg mL -1 end concentration) and inoculated with different fungi. All incubation samples (with the same conditions as in 2.3.) had two controls: the fungus without any NSAID, and the NSAID in the medium without the fungus. After the 24 days' incubation time elapsed, samples were lyophilized. To the lyophilized samples, 500 µL of water was added until most of the pellet redissolved. Thereafter, 4.50 mL of MeOH was added, the samples were mixed thoroughly, sonicated for a minute and centrifuged (13000 rpm, 1 minute) to remove the mycelia. The supernatant was used for LC-MS analysis directly, using the following conditions: LC was performed on a Kinetex XB-C 18 , (100 x 2.10mm, 2.6m, Phenomenex, Torrance, CA, USA) column, using an Accela HPLC system (Thermo Electron Corp., San Jose, CA, USA) eluted with a gradient of methanol (A) and water (B) containing 0.1% NH 4 OAc each. The gradient was from 10% of A to 100% A over 15 min, held for 5 minutes, returned to initial conditions in 0.10 minutes and held for 3 min to equilibrate the column. The LC system was coupled to a Thermo LTQ XL linear ion trap mass spectrometer (Thermo Electron Corp., San Jose, CA, USA) operated in a full scan positive or negative ion ESI mode (m/z range was 150-2000 Da for the main experiments). The ion injection time was set to 100 ms. ESI parameters were: source temperature 275 °C; spray voltage 4 kV; capillary temperature 275°C; sheath gas flow 15 units N 2 ; auxiliary gas flow 8 units N 2 . The tray temperature was set to 20°C and the column oven was set to 30 °C to perform the optimal retention of the compounds in the samples. The injection amount was 1 L for each sample.
The peaks (m/z at retention time) found in LC-MS, which 1., were present in the medium of the fungus with NSAID (at least 5x10 2 peak height); 2., were not present in the fungal metabolome control (fungus in medium without NSAID); 3., were not present in the noninoculated medium incubated with NSAID, were considered fungal NSAID metabolites. The peak list obtained was subjected to fragmentation in ESI-MS/MS in another run, to obtain structural information. The chromatographic conditions were the same.
Statistical evaluations and software.
LC-MS data evaluation was done with mzMine 2.10 (Pluskal et al., 2010) and the R package XCMS 1.42.0 (Smith et al., 2006) . Data analysis was aided by using scripts written in R 3.1.2 (R Development Core Team, 2009), for plotting, ggplot2 was used (Wickham, 2009 ). ANOVA models were implemented in R and were used to statistically test hypotheses, followed by Dunnett's post-hoc test, where appropriate. The p values were considered significant when p < 0.05. Marvin 15.2.9.0-master-2515, 2015, ChemAxon (http://www.chemaxon.com), was used for drawing, displaying and characterizing chemical structures.
Results
Decomposition of NSAIDs by plant-associated fungi
The growth of the tested fungi was not inhibited by the added high amount of the NSAID mixture (sum of 500 µg mL -1 ). The same strains also tolerated the high amount of polyphenolic substances well in our previous study (Gonda et al., 2013a) . In controls, no significant decrease of any of the NSAIDs was observed (Fig.2.) , meaning, that spontaneous (hydrolytic or oxidative) decomposition did not occur during the experiments.
The fungal inoculation, however, significantly decreased the NSAID amount in the media after 28 days of incubation (p = 1.38e-15, 0.00526, 4.83e-10, 6.96e-16 and 5.21e-10 for IBU, PIR, MEF, DIF and DIC, respectively; n=3, ANOVA). The species showed marked differences in the ability to decrease the amount of NSAIDs in solution, and the sensitivity of the NSAIDs to enzymatic modification was also quite different. The most active strain was Aspergillus nidulans, which was the only strain that could decrease the amount of all NSAIDs in the test. It also caused complete biotransformation of the 100 µg mL -1 IBU by the end of the incubation time (p<0.001, Fig.2.c.) . A.
niger and the endophytic B. tetramera could biotransform three of the five NSAIDs: IBU, MEF and DIF (Fig.2.) . The typical endophyte E. nigrum could metabolize two NSAIDs: IBU and MEF (p<0.05).
Several of the strains, however, could only metabolize IBU (p<0.05, Fig.2 
.c.).
As it can be seen, the NSAIDs without any metabolism-resistant groups, i.e. IBU, MEF could be well metabolized by most strains (Fig.2.c.,d. ). On the other hand, the halogenated aromatics (DIC and DIF), as well as the cyclic sulfonamide PIR were much less prone to decomposition (Fig.2.a.,b .,e.).
Metabolites of NSAIDs.
After successful screening for activity, a selected subset of fungi (A. niger, A. nidulans, B. tetramera and E. nigrum) were inoculated again with different NSAIDs separately for metabolite screening. As controls, the NSAID containing media alone, and the media of fungi without NSAIDs were used. Therefore, degradation products that might arise from spontaneous oxidative or hydrolytic decomposition, or compounds that can also be parts of the fungal metabolome, were excluded from the analysis.
To find possible metabolites, samples were grouped into sets consisting of fungusfungus+NSAID -NSAID, and subjected to automatic peak search, using parameters as in 2.4. This resulted in a preliminary peak set of 57 peaks. Another set was obtained by targeted screening for mono-, dihydroxy-compounds, and compounds that contained carboxyl groups instead of a methyl moiety. After removing the adducts, isotopes, as well as high m/z peaks found by the automatic search unlikely to be NSAID metabolites, the samples were reinjected and the selected list of peaks was fragmented in LC-MS 3 . Identification was started in negative ion mode, with interesting peaks (i.e. peaks falling in the estimated retention time range for NSAID metabolites, and having a similar m/z to the initial molecules) rechecked in positive ion mode under the same chromatographic conditions. The compounds that could be identified as NSAID metabolites, are shown in Table 1 . Several other peaks likely to be metabolites of the NSAIDs could be detected, but unfortunately, their abundance was insufficient to subject them to MS Table 1. ). These were identified as hydroxy-DIC derivatives as compared with the MS/MS data (Webster et al., 1998; Kallio et al., 2010) . Although the actual position of the hydroxyl group could not be determined from the MS/MS alone, the fragmentation fully supported the proposed structure. The m/z 150 at 4.32 min is the result of the cleavage of the aromatic amine, the fungus successfully removed the dichloro-aromatic moiety from DIC. It can be observed, that the dehalogenation of the chlorinated aromatic group did not occur during the metabolism, i.e. no monochlorine aromatic breakdown product was found. The detected high abundance of the new metabolites account for the decrease of DIC in solution. The dominant metabolite was a OH-DIC isomer at 8.62 min, with a high abundance only an order of magnitude less than that of DIC. Assuming similar sensitivity for these two, the metabolite was likely to be present in the 1-10 µg mL -1 range in the medium. This suggests that after further optimization, A. nidulans could also be used for selective transformation of DIC.
A metabolite of DIF was identified in the medium of A. nidulans. The compounds was found to be a hydroxy-DIF metabolite, with the exact position of the -OH group not assigned. So far, no fungal metabolites of DIF have been described in the literature. The compound showed peaks identical to those described in the literature (Macdonald et al., 1991; Dickinson et al., 1994) . As in the case of DIC, the halogenated ring was untouched; MS (Paíga et al., 2015) , most probably the isobutyl sidechain is hydroxylated. The found fragmentation pathway was similar to that described for alkyl-phenols in (Bajpai et al., 2005 ).
Metabolism of MEF by A. niger, A. nidulans, B. tetramera and E. nigrum led to new peaks with
the m/z 256 at 8.18 and 8.55 minutes. While the typically endophytic Epicoccum nigrum and strain B. tetramera created huge amounts of the first metabolite (rt 8.1 min), A. nidulans made significantly smaller amounts, but both peaks were observed. In the medium of A. niger, the amount of this metabolite was much less, but still, detectable. These compounds were identified as hydroxy-MEF isomers, as suggested by the fragmentation pattern in negative ion mode (Wing Lam et al., 2007) . . The structures were supported by the fragmentation in both negative and positive ion mode. In this case, both the pyridine side chain and the sulfonamide part was found to be hydroxylated.
Discussion
Altogether, in 18 of the 45 cases has significant decrease been found, which highlights the potential of plant-associated fungi from medicinal plant materials for biodegradation of NSAIDs. It should be noted, that the fungi were isolated from the plant material with a procedure that leads to the mixture of endophytic and epiphytic fungi. Despite this, the adaptation to the phenolic compounds was evident, as shown previously by the ability to metabolise phenolics (Gonda et al., 2013a) .
Decomposition of NSAIDs by fungi is previously described for a few of the tested molecules in the literature. The current study has shown, that the concentration of diflunisal and piroxicam can also be reduced by fungal treatment. Most of the studies used very low concentrations, and also, most studies used white-rot fungi. For example, the white-rot fungus Phanerochaete chrysosporium was able to metabolize 5 µg mL-1 DIC by its lignin peroxidase (Zhang and Geißen, 2010) . Another white-rot fungus, Trametes versicolor successfully transformed higher concentrations (10 µg mL-1) of DIC into 4'-OH-DIC and 5-OH-DIC . Our experimental setup shows the high tolerance of these fungi to the presence of high concentrations of NSAIDs (100 µg mL -1 order of magnitude), and the potency of fungi other than wood decay fungi in pharmaceutical biotransformation. It is also important to emphasize, that the efficacy is likely due to the chemical similarity of the NSAIDs and the small phenolic metabolites the strains are adapted to.
As decrease in the original molecule's concentration does not mean full decomposition of the compounds, a subset of fungi -NSAID combinations were screened for NSAID metabolites by LC-ESI-MS/MS. Altogether, ten metabolites were tentatively identified from the media of different wildtype epiphytic and endophytic fungi. Nine of these metabolites were shown to be either mono-, or dihydroxy derivatives of the original anti-inflammatory drug molecules. The products generated by the fungi of the current study are similar to those found in the phase I metabolism of mammalsmetabolism to various hydroxylated products was shown for these pharmaceuticals (Macdonald et al., 1991; Wing Lam et al., 2007; Stülten et al., 2008; Tevell Åberg et al., 2009; Borges et al., 2010) . These metabolites can be less toxic or more toxic compared to the original compounds. In a study using an ex vivo intestinal model, metabolism inhibitors increased DIC toxicity, and also reduced the generated amount of 4'-OH-DIC, 5-OH-DIC (Niu et al., 2015) . Oxydative biotransformation of DIC and MEF also reduced the toxicity against a freshwater crustacean in (Hata et al., 2010) . In contrast, during the metabolism of IBU into 1,2-dihydroxy-IBU by Trametes versicolor, increase in toxicity was observed in Microtox bioassay (Marco-Urrea et al., 2009b) . The oxidized NSAIDs (as shown for DIC) can also give rise to toxic adduct-forming reactive species when metabolized further (Tang et al., 1999) . It is also important to note however that as oxidative modification increases the polarity of the compounds, their bioaccumulation is likely to be reduced, and their accessibility by enzymes is increased (Esser, 1986 ) helping later mineralization. Altogether, the change of toxicity of the NSAIDs by fungal metabolism is hard to predict without detailed toxicological studies on the metabolites themselves.
In a few cases, no metabolite could be detected by LC-MS, but the decrease in the solution was significant. This could have been the result of either metabolites that show low ionization and poor detectability by MS, or perhaps in a few cases, complete degradation.
The high amount of detected metabolites and the high chance of finding highly active fungi in such a small set of species clearly shows the potency of dried medicinal plant materials as sources of fungi useful for biotransformation. It is also worth to mention, that B. tetramera and E. nigrum were previously (Gonda et al., 2013a) shown to efficiently decompose the plant phenolic compound acteoside, and that many of these strains (including A. nidulans and B. tetramera) were able to release high amounts of small, oxidized phenolic compounds from the plant metabolome (Gonda et al., 2013a) .
Thus, the high chance of finding fungi that are able to oxidize NSAIDs was at least in part due to the adaptation to biotransformation of small phenolic compounds of similar polarity highly abundant in the plant. It is also worth to mention, that the most easily metabolized IBU (8 of 9 strains caused significant decomposition) is the most similar to these phenolic natural products.
Dried medicinal plant materials can contain very significant amounts of spores of possibly adapted fungi, and also suitable nutrients for these fungi. This is especially true for products that are improper for human use because of their poor microbiological quality -these can contain up to 10 7 -10 8 fungi per g dry weight (Gonda et al., 2012) . Therefore, these materials should be tested in more practice oriented approaches for degradation or biotransformation of pharmaceuticals in the future.
Conclusions
The results of the current study suggest that dried medicinal plant materials can be excellent sources of fungi with high catalytic activity, regardless of the fungi being endophytic or epiphytic. The evolutionary adaptation of these fungi towards metabolism of bioactive natural products makes these strains tolerant to high concentrations of pharmaceuticals of similar structure, and applicable for transforming or biodegrading these pharmaceuticals. The biotransformation steps were found to resemble those of phase I mammalian metabolism. The wide availability of the tested source material can also make possible applications easily testable. The results also suggest, that fungi other than white-rot fungi should be investigated more in-depth for biodegradation processes.
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